Tag Archives: systolic blood pressure

Boehringer Ingelheim Reports Cardiovascular Safety and Metabolic Findings for Survodutide in Phase III Trial

Boehringer Ingelheim corporate logo

SYNCHRONIZE-CVOT met its non-inferiority endpoint for major cardiovascular events and showed changes in blood pressure, waist circumference and weight at Week 72. IN BRIEFKEY TAKEAWAYSFAQs Boehringer Ingelheim announced that the Phase III SYNCHRONIZE-CVOT study of investigational survodutide met its cardiovascular … Read the full press release →

European Society of Cardiology Highlights Meta-Analysis Linking Four to Six Daily Wholegrain Servings With Improvements in Major Cardiovascular Risk Factors

(IN BRIEF) A systematic review and meta-analysis published in the European Heart Journal has found that consuming approximately four to six servings of wholegrain foods per day is associated with improvements in several cardiovascular and metabolic risk factors. The analysis … Read the full press release →

ESC Congress 2026 Research Calls for Routine Adherence Checks in Hypertension Care

(IN BRIEF) A new analysis to be presented at ESC Congress 2026 in Munich shows that patients who do not take blood pressure-lowering medicines as prescribed may miss out on important cardiovascular benefits. The meta-analysis, conducted within the Blood Pressure … Read the full press release →

AstraZeneca Reports Positive Phase III Bax24 Results, Reinforcing Baxdrostat’s Potential as a Novel Treatment for Hard-to-Control Hypertension

(IN BRIEF) AstraZeneca reported positive Phase III Bax24 trial results showing that baxdrostat achieved a significant and clinically meaningful reduction in 24-hour ambulatory systolic blood pressure in patients with treatment-resistant hypertension. The once-daily oral therapy was well tolerated and maintained … Read the full press release →